Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
FGF
>>
Phase 4
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
68
136
204
272
340
408
476
544
612
680
Focus V
(anlotinib) / Advenchen, Sino Biopharm
Lenvima
(lenvatinib) / Eisai, Merck (MSD)
Stivarga
(regorafenib) / Bayer
Votrient
(pazopanib) / Novartis, BeiGene
nintedanib
/ Generic mfg.
Sulanda
(surufatinib) / Hutchmed
Iclusig
(ponatinib) / Takeda, Otsuka
Kepivance
(palifermin) / SOBI, Amgen
Pemazyre
(pemigatinib) / Incyte
Retevmo
(selpercatinib) / Eli Lilly
Crysvita
(burosumab-twza) / Ultragenyx, Kyowa Kirin
Gavreto
(pralsetinib) / Rigel
